SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO: 4589) (“Acucela” or the “Company”), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced that shareholders have elected four new members to the Company’s Board of Directors (the “Board”) at today’s special meeting of the Company’s shareholders (the “Special Meeting”). At the Special Meeting,
Injected cultivated cells and Rho kinase inhibitor eye drops look like promising treatments for corneal endothelial dysfunction, a researcher reports. Medscape Medical News
Tyrogenex has initiated a phase 2 study of X-82 for the treatment of wet age-related macular degeneration, according to a press release.The treatment is a dual inhibitor of VEGF and PDGF that is administered orally.
STAAR Surgical reported $18.9 million in net sales in the first quarter 2015, a 7% decrease from $20.2 million in the first quarter of the previous year, according to a press release.The decline in sales was 3% after a constant currency basis adjustment.
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced new data will be presented on the company’s sustained release technology at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting at the Colorado Convention Center in Denver, Colorado, from May 3-7, 2015. The data presented will focus on the
BOSTON — Mobile apps are becoming increasingly common in health care, with 20,000 available on iTunes and the Android Store related to medicine, according to Sameer Badlani, MD, FACP, chief health information officer at Intermountain Healthcare in Salt Lake City.“Apps are like sushi: You really have to try a few and see what you like,” Badlani said during his presentation here at the ACP Internal Medicine meeting, where he discussed the various categories of medical apps and shared with the audience those he has found most useful.